Health Care: Drugs

Amgen Inc (AMGN: NASDAQ)

$167.91 n/a | n/a%
04/24/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 20.06B 18.68B 17.26B 15.58B
Cost of Sales 2.33B 2.06B 2.12B 1.66B
Gross Operating Profit 17.73B 16.62B 15.14B 13.92B
Selling, General, and Administrative Expenses 4.70B 5.18B 4.80B 4.49B
Research & Development 4.30B 4.08B 3.38B 3.17B
Operating Income before D & A (EBITDA) 8.74B 7.35B 6.96B 6.27B
Depreciation & Amortization 2.09B 1.29B 1.09B 1.06B
Interest Income 0.00 0.00 485.00M 448.00M
Other Income - Net -454.00M -196.00M -295.00M -896.00M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 6.19B 5.87B 6.06B 4.76B
Interest Expense 606.00M 602.00M 1.05B 610.00M
Pre-Tax Income 5.58B 5.26B 5.01B 4.15B
Income Taxes 427.00M 184.00M 664.00M 467.00M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 5.16B 5.08B 4.34B 3.68B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 5.16B 5.08B 4.34B 3.68B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 5.16B 5.08B 4.34B 3.68B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.16B 5.08B 4.34B 3.68B
Preferred Dividends
Net Income Available To Common 5.16B 5.08B 4.34B 3.68B
Basic EPS from Continuing Ops. 6.80 6.75 5.61 4.07
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 6.80 6.75 5.61 4.07
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 6.80 6.75 5.61 4.07
Basic Normalized Net Income/Share 6.80 6.75 5.61 4.07
EPS fr Continuing Ops. 6.70 6.64 5.52 4.04
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 6.70 6.64 5.52 4.04
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 6.70 6.64 5.52 4.04
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
6.70 6.64 5.52 4.04
Dividends Paid per Share 2.44 1.88 1.44 0.56

Portfolios with AMGN

Latest AMGN Headlines from TheStreet

More Financial News for AMGN

Press Releases for AMGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter